Strumento inattivo

Azioni ARMO Biosciences Inc

Azioni

Durata

Periodo

Stile

ARMO Biosciences : Lilly Completes Acquisition of ARMO BioSciences	22/06/18
Bragar Eagel & Squire, P.C. : is Investigating the Board of Directors of ARMO BioSciences, Inc. (ARMO) on Behalf of Stockholders and Encourages Investors to Contact the Firm	10/05/18
ARMO Biosciences : Lilly to buy Armo Biosciences for $1.6 billion to bolster cancer pipeline	10/05/18
NASDAQ COMPOSITE : Wall Street soulagée par un modeste rebond de l'inflation	10/05/18
ARMO Biosciences : Eli Lilly acquiert Armo Biosciences pour 1,6 milliard de dollars	10/05/18

Dirigenti	Titolo	Età	Da
Martin Oft FOU	Founder	-	23/06/10
Philip Johnson CEO	Chief Executive Officer	59	21/06/18
Darren J. Carroll PSD	President	-	21/06/18

Amministratori	Titolo	Età	Da
Darren J. Carroll PSD	President	-	21/06/18
Philip Johnson		59	-
Gordon Brooks BRD	Director/Board Member	-	21/06/18

Settore

	Variaz. 1 gen.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+7,52%	111 Mrd
REGENERON PHARMACEUTICALS, INC.	+11,38%	106 Mrd
BIONTECH SE	-12,64%	22,24 Mrd
ARGENX SE	+0,44%	21,25 Mrd
GENMAB A/S	-4,18%	18,97 Mrd
WUXI APPTEC CO., LTD.	-37,85%	18,52 Mrd
BEIGENE, LTD.	-8,58%	16,81 Mrd
SAREPTA THERAPEUTICS, INC.	+37,41%	12,54 Mrd
LEGEND BIOTECH CORPORATION	-23,95%	8,09 Mrd